CIK 1053321
OMERS ADMINISTRATION Corp
Institutional 13F holdings & portfolio
Holdings
1,030
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 901–950 of 1,030
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| PRLD | PRELUDE THERAPEUTICS INC | 73K | $100K–$500K | SH |
| CABA | CABALETTA BIO INC | 95K | $100K–$500K | SH |
| SRI | STONERIDGE INC | 36K | $100K–$500K | SH |
| AVBC | AVIDIA BANCORP INC | 12K | $100K–$500K | SH |
| ASYS | AMTECH SYS INC | 17K | $100K–$500K | SH |
| LXEO | LEXEO THERAPEUTICS INC | 21K | $100K–$500K | SH |
| TGEN | TECOGEN INC NEW | 42K | $100K–$500K | SH |
| TFX | TELEFLEX INCORPORATED | 2K | $100K–$500K | SH |
| PCTY | PAYLOCITY HLDG CORP | 1K | $100K–$500K | SH |
| TONX | TON STRATEGY CO | 103K | $100K–$500K | SH |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 105K | $100K–$500K | SH |
| OVID | OVID THERAPEUTICS INC | 125K | $100K–$500K | SH |
| ALTS | ALT5 SIGMA CORP | 186K | $100K–$500K | SH |
| COYA | COYA THERAPEUTICS INC | 35K | $100K–$500K | SH |
| IMDX | INSIGHT MOLECULAR DIA INC | 26K | $100K–$500K | SH |
| SUIG | SUI GROUP HOLDINGS LIMITED | 117K | $100K–$500K | SH |
| STEM | STEM INC | 13K | $100K–$500K | SH |
| PATH | UIPATH INC | 12K | $100K–$500K | SH |
| VRCA | VERRICA PHARMACEUTICALS INC | 23K | $100K–$500K | SH |
| ELTX | ELICIO THERAPEUTICS INC | 24K | $100K–$500K | SH |
| NEXN | NEXXEN INTL LTD | 28K | $100K–$500K | SH |
| STEX | STREAMEX CORP | 60K | $100K–$500K | SH |
| PEPG | PEPGEN INC | 28K | $100K–$500K | SH |
| FWDI | FORWARD INDS INC N Y | 27K | $100K–$500K | SH |
| IRD | OPUS GENETICS INC | 88K | $100K–$500K | SH |
| ARMP | ARMATA PHARMACEUTICALS INC | 28K | $100K–$500K | SH |
| BLNK | BLINK CHARGING CO | 265K | $100K–$500K | SH |
| LHAI | LINKHOME HLDGS INC | 23K | $100K–$500K | SH |
| UPXI | UPEXI INC | 101K | $100K–$500K | SH |
| PLCE | CHILDRENS PL INC NEW | 43K | $100K–$500K | SH |
| TNYA | TENAYA THERAPEUTICS INC | 236K | $100K–$500K | SH |
| CMTL | COMTECH TELECOMMUNICATIONS C | 32K | $100K–$500K | SH |
| SAVA | CASSAVA SCIENCES INC | 84K | $100K–$500K | SH |
| VERI | VERITONE INC | 36K | $100K–$500K | SH |
| DTCX | DATACENTREX INC | 60K | $100K–$500K | SH |
| MDXH | MDXHEALTH SA | 46K | $100K–$500K | SH |
| FACTU | FACT II ACQUISITION CORP | 15K | $100K–$500K | SH |
| AREC | AMERICAN RES CORP | 64K | $100K–$500K | SH |
| DNMXU | DYNAMIX CORP III | 16K | $100K–$500K | SH |
| SABS | SAB BIOTHERAPEUTICS INC | 42K | $100K–$500K | SH |
| — | HYPERLIQUID STRATEGIES INC | 44K | $100K–$500K | SH |
| LGCY | LEGACY ED INC | 15K | $100K–$500K | SH |
| SCLX | SCILEX HOLDING CO | 12K | $100K–$500K | SH |
| OPEN | OPENDOOR TECHNOLOGIES INC | 25K | $100K–$500K | SH |
| SND | SMART SAND INC | 37K | $100K–$500K | SH |
| TRON | TRON INC | 115K | $100K–$500K | SH |
| ETHZ | ETHZILLA CORPORATION | 29K | $100K–$500K | SH |
| DMIIR | DRUGS MADE IN AMER ACQ II CO | 1.0M | $100K–$500K | SH |
| CBIO | CRESCENT BIOPHARMA INC. | 12K | $100K–$500K | SH |
| ONL | ORION PROPERTIES INC | 58K | $100K–$500K | SH |